Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 References  














SLU-PP-332







Add links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


SLU-PP-332
Names
Preferred IUPAC name

4-hydroxy-N-[(Z)-naphthalen-2-ylmethylideneamino]benzamide

Other names

SLU-PP-332

Identifiers

CAS Number

3D model (JSmol)

ChemSpider

PubChem CID

  • InChI=1S/C18H14N2O2/c21-17-9-7-15(8-10-17)18(22)20-19-12-13-5-6-14-3-1-2-4-16(14)11-13/h1-12,21H,(H,20,22)/b19-12-

    Key: RNZIMBFHRXYRLL-UNOMPAQXSA-N

  • C1=CC=C2C=C(C=CC2=C1)/C=N\NC(=O)C3=CC=C(C=C3)O

Properties

Chemical formula

C18H14N2O2

Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Infobox references

SLU-PP-332 is a compound which is a potent but non-selective estrogen-related receptor (ERR) agonist, acting most strongly at ERRα with an EC50 of 98 nM. It was found to counteract metabolic syndrome in mice, suggesting a possible role for compounds from this class as medications for the treatment of obesity.[1][2][3][4][5]

References[edit]

  1. ^ US 8680150, Zhi L, Hudson AR, Van Oeveren CA, Roach SL, Pickens JC, Shen Y, Cuervo C, Valdez LJ, Basinger J, Grant VH, "Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors.", issued 25 March 2014, assigned to Ligand Pharmaceuticals Inc. 
  • ^ Billon C, Sitaula S, Banerjee S, Welch R, Elgendy B, Hegazy L, et al. (April 2023). "Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity". ACS Chemical Biology. 18 (4): 756–771. doi:10.1021/acschembio.2c00720. PMID 36988910. S2CID 257803892.
  • ^ Billon C, Schoepke E, Avdagic A, Chatterjee A, Butler AA, Elgendy B, et al. (September 2023). "A Synthetic ERR Agonist Alleviates Metabolic Syndrome". The Journal of Pharmacology and Experimental Therapeutics. 388 (2): 232–240. doi:10.1124/jpet.123.001733. PMID 37739806. S2CID 262147173.
  • ^ Wang XX, Myakala K, Libby AE, Krawczyk E, Panov J, Jones BA, et al. (September 2023). "Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney". The American Journal of Pathology. 193 (12): 1969–1987. doi:10.1016/j.ajpath.2023.07.008. PMC 10734281. PMID 37717940. S2CID 262046570.
  • ^ "Exercise-mimicking drug sheds weight, boosts muscle activity in mice". news.ufl.edu. Retrieved 2023-10-05.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=SLU-PP-332&oldid=1217157930"

    Categories: 
    Phenols
    Benzamides
    Naphthalenes
    Hydrazides
    Exercise mimetics
    Estrogen-related receptor modulators
    Hidden categories: 
    Articles without EBI source
    Articles without KEGG source
    Articles without UNII source
    Articles containing unverified chemical infoboxes
    Chembox image size set
    Articles with short description
    Short description matches Wikidata
     



    This page was last edited on 4 April 2024, at 04:59 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki